Intranasal sufentanil for cancer-associated breakthrough pain.
about
Reporting characteristics of cancer pain: a systematic review and quantitative analysis of research publications in palliative care journals.Recent advances in the use of opioids for cancer painA systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project.Final days at home.Recent development in therapeutics for breakthrough pain.Is morphine still the best reference opioid?Derniers jours à la maison.
P2860
Q33919787-64FFADA8-D427-406D-BBAC-7BE21171698FQ34418203-56A418DB-91E6-4578-8C31-AB93645C8D8EQ37895002-EB8EF4FD-AEB9-4BB9-BE58-EC269FC09011Q40634446-9660D832-1B5E-4791-8589-2AE270B1022BQ43085276-7F68BE73-9EE9-42D9-8B29-6585A7783B75Q44344049-D2E87C80-37E8-4B35-AE96-44E48A5B2C48Q46110654-F1B9F1F2-B336-4624-A5B4-23BFE8625C61
P2860
Intranasal sufentanil for cancer-associated breakthrough pain.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Intranasal sufentanil for cancer-associated breakthrough pain.
@en
Intranasal sufentanil for cancer-associated breakthrough pain.
@nl
type
label
Intranasal sufentanil for cancer-associated breakthrough pain.
@en
Intranasal sufentanil for cancer-associated breakthrough pain.
@nl
prefLabel
Intranasal sufentanil for cancer-associated breakthrough pain.
@en
Intranasal sufentanil for cancer-associated breakthrough pain.
@nl
P2093
P2860
P356
P1433
P1476
Intranasal sufentanil for cancer-associated breakthrough pain
@en
P2093
P2860
P356
10.1177/0269216308100249
P50
P577
2009-01-01T00:00:00Z